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Abstract
Background: Variability of gene expression in human may link gene sequence variability and phenotypes; however, non-
genetic variations, alone or in combination with genetics, may also influence expression traits and have a critical role in
physiological and disease processes.
Methodology/Principal Findings: To get better insight into the overall variability of gene expression, we assessed the
transcriptome of circulating monocytes, a key cell involved in immunity-related diseases and atherosclerosis, in 1,490
unrelated individuals and investigated its association with .675,000 SNPs and 10 common cardiovascular risk factors. Out
of 12,808 expressed genes, 2,745 expression quantitative trait loci were detected (P,5.78610
212), most of them (90%)
being cis-modulated. Extensive analyses showed that associations identified by genome-wide association studies of lipids,
body mass index or blood pressure were rarely compatible with a mediation by monocyte expression level at the locus. At a
study-wide level (P,3.9610
27), 1,662 expression traits (13.0%) were significantly associated with at least one risk factor.
Genome-wide interaction analyses suggested that genetic variability and risk factors mostly acted additively on gene
expression. Because of the structure of correlation among expression traits, the variability of risk factors could be
characterized by a limited set of independent gene expressions which may have biological and clinical relevance. For
example expression traits associated with cigarette smoking were more strongly associated with carotid atherosclerosis
than smoking itself.
Conclusions/Significance: This study demonstrates that the monocyte transcriptome is a potent integrator of genetic and
non-genetic influences of relevance for disease pathophysiology and risk assessment.
Citation: Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and Beyond – The Transcriptome of Human Monocytes and Disease
Susceptibility. PLoS ONE 5(5): e10693. doi:10.1371/journal.pone.0010693
Editor: Zolta ´n Bochdanovits, VU University Medical Center and Center for Neurogenomics and Cognitive Research, VU University, Netherlands
Received March 15, 2010; Accepted April 26, 2010; Published May 18, 2010
Copyright:  2010 Zeller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Gutenberg Heart Study is funded through the government of Rheinland-Pfalz (Stiftung Rheinland Pfalz fu ¨r Innovation, contract number AZ 961-
386261/733), the research programs Wissen schafft Zukunft and Schwerpunkt Vaskula ¨re Pra ¨vention of the Johannes Gutenberg-University of Mainz and its
contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Heart Study. Specifically, the research
reported in this article was supported by the National Genome Network NGFNplus (contract number project A3 01GS0833) by the Federal Ministry of Education
and Research, Germany. For this particular research paper, Boehringer Ingelheim provided payment of two employees for expression microarray analyses and
array purchase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: In this study, Boehringer Ingelheim provided payment for two employees for expression microarray analyses and array purchase and
PHILIPS Medical Systems provided instruments for ultrasound studies. However, this does not alter the authors’ adherence to all the PLoS ONE policies on sharing
data and materials, as detailed online in the guide for authors of the Journal.
* E-mail: blankenberg@2-med.klinik.uni-mainz.de (SB); francois.cambien@upmc.fr (FC)
. These authors contributed equally to this work.
Introduction
The transcriptome, i.e. the whole set of RNA transcripts in a
cell, is generally conceived as a system whose major function is to
pass information encoded in the genome sequence to the realm of
phenotypes that underlie physiological and pathological traits.
This messenger paradigm justifies the current interest for the
genetics of gene expression [1–6] which has been further enhanced
by the numerous associations between genetic markers and
diseases reported in recent genome-wide association studies
(GWAS) and the expected relevance of genome wide expression
(GWE) to characterize the biological basis of these associations
[7–10]. However the variability of gene expression not only
reflects genetic variation but depends on other factors as well such
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10693as environmental exposures [11,12], metabolic conditions [13],
ageing [14,15] or gender [16–17].
Based on these premises we reasoned that if the state of the
transcriptome and its changes are important determinants of cell
functions, differences in transcript abundance whatever their
origin, genetic or non genetic, may contribute to disease
pathogenesis. Moreover, the transcriptome might integrate
information from numerous sources and inform on the current
pathophysiological state of the organism. To assess these
possibilities, a global characterization of the variability of the
transcriptome, integrating genetic and non genetic influences was
undertaken. The study focused on peripheral blood monocytes
because these cells may be isolated from an easily accessible tissue
and play a key role in the pathogenesis of immune disorders and
atherosclerosis-related diseases [18]. In addition, working on a
single cell type reduces the complexity of transcriptome data and
may avoid possible biases resulting from the heterogeneous cell-
types distribution in different samples as it is the case when using
whole blood or leucocytes RNAs.
Results
The genome-wide expression of circulating monocytes
To reduce potential artefacts, fresh samples were collected and
processed in a short period of time according to a very strict
protocol. Monocytes were obtained from 1,490 unrelated
individuals, 730 women and 760 men, aged 35 to 74 years,
recruited in the Gutenberg Heart Study (GHS), a community-
based project conducted in a single centre in the region of Mainz
(Germany) (Table 1). GWE profiles were generated using Illumina
Human HT-12 expression BeadChips, and after normalization
and filtering out genes undetected in monocytes or non-well
characterized (see Materials and Methods), 12,808 expressions
traits (averaged over probes) remained for analysis.
Identification of eSNPs and eQTLs
Genotyping was performed using Affymetrix 6.0 arrays. After
filtering out SNPs poorly performing or having a minor allele
frequency ,0.01, 675,350 SNPs were kept for further analyses. All
associations between SNPs and expression traits with a P-value
,10
25 (n.225,000) were stored in the ‘‘GHS_Express’’ database
(‘‘GHS_Express’’ is available online, see Methods S1). At a study-
wise threshold of significance correcting for the number of SNPs
and expressions (P,5.78610
212), 37,403 associations, involving
29,912 SNPs and 2,745 expression traits (referred to as eSNPs and
eQTLs, respectively), were identified (Table 2). The median
number of eSNPs by eQTL was 11 with an interquartile range of 4
to 26. Owing to its large sample size, the study had an 80% power
to detect a SNP effect accounting for 4% or more of the variability
(R
2) of any expression trait. Among the 2,745 significant eQTLs,
the R
2 observed for the best eSNP varied from 3.1% to .80%
with a median of 7.7%. For 290 eQTLs, the R
2 was greater than
25%.
Cis versus trans associations
Associations involving SNPs located within 1 Mb of either the
59 or 39 end of the associated gene were considered cis (File S1) and
other associations were considered trans. In accordance with
previous results [2–6], most of the genetic variability affecting the
transcriptome was of cis origin. At study-wise significance, the
number of cis and trans eQTLs were 2,477 and 349, respectively,
yielding a cis/trans ratio of 7.1 (81 eQTLs were both cis- and trans-
modulated). At less stringent levels of significance the number of
trans associations considerably increased, as expected by chance,
whereas the number of cis eQTLs only modestly increased,
indicating that the high stringency used for cis eQTLs identifica-
tion did not result in an important under-estimation of the true
number of cis eQTLs (Figure 1).
Comparison with previous GWAS of gene expression
We examined the overlap between the cis eQTLs identified in
the present study and those found in three previous association
studies in which gene expression was explored in LCLs [1,2] and
hepatic cells [3]. For this comparison, a significance threshold of
3.9610
26 (Bonferroni-corrected for 12,808 genes) was used for
the analysis of eQTLs in GHS data, corresponding to a single
hypothesis tested per gene. Among the cis eQTLs considered
significant in each of the studies and involving expression traits
detected in GHS, 66.7%, 56.5% and 54.1%, respectively, were
significant in our data (Table 3, Files S2–S4). The proportion of
cis eQTLs that replicated in GHS increased with the increasing
level of significance reported in each study, consistent with the
fact that stronger associations are more robust and more likely to
be shared by different types of cells. These comparisons revealed
a relatively high rate of replication of the previous findings in
GHS. However, as a consequence of its greater power, P-values
observed in GHS were considerably lower than those previously
reported (Figure 2).
We also examined the overlap between cis eQTLs in GHS and
cis-heritable eQTLs found by expression profiling of lymphocyte
RNA in the San Antonio Family Heart Study (SAFHS)
4. Among
the eQTLs with a cis heritability $0.1 in SAFHS, 62% were
significantly cis modulated in GHS, and this proportion reached
89% for heritabilities $0.6 (Figure 3, File S5).
Trans associations showed much weaker consistency across
studies. Among the 50 eQTLs having a trans lod score .4.0 in
SAFHS [4] with corresponding expression detected in GHS, only
one, MAPK8IP1, was replicated in GHS (P,10
2300). Replication
of the trans associations in studies of similar power as the present
one would be of interest.
Identifying eQTLs that may result from the presence of
SNPs in probe sequences
For all probes present on the Illumina HT12 array, a systematic
search for sequence polymorphisms was undertaken, using the
HapMap database as reference (Release 27; Phase II+III, Feb09,
Table 1. Description of the GHS study population.
Men Women P-value
N 760 730
Age (years) 56.4 (10.6) 53.9 (11.2) 2.4610
25
BMI (kg/m
2) 27.6 (3.9) 26.2 (5.1) 1.2610
28
HDL cholesterol (mg/dL) 54.4 (14.9) 69.2 (17.8) 2.2610
216
LDL cholesterol (mg/dL) 133.7 (36.1) 133.0 (36.8) NS
Triglycerides (mg/dl) 143.2 (97.5) 114.4 (56.8) 2.1610
212
Systolic blood pressure (mmHg) 135.8 (16.7) 128.5 (18.2) 2.3610
216
Diastolic blood pressure (mmHg) 85.2 (9.6) 81.2 (9.5) 5.4610
216
Current smoker 128 (16.8%) 113 (15.5%) NS
Plasma CRP (mg/L) (sqrt) 1.509 (0.818) 1.545 (0.743) NS
Plasma glucose (mg/dL) 97.8 (18.5) 91.8 (15.4) 1.1610
24
Values are means (SD) or numbers (%).
doi:10.1371/journal.pone.0010693.t001
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whose expression was associated with cis eSNPs, 173 (7%) were
probed by one or several polymorphic sequences (180 probes)
(Table S1). For 32 of these probes, the HapMap SNP was present
on the Affymetrix array used in this study and for 41 other probes,
the HapMap SNP had one or several perfect proxies on the array.
For those eQTLs, we cannot exclude the possibility of an
artefactual association due to a differential binding of the probe
to its target sequence.
Gene expression, a link between DNA sequence
variability and clinical phenotypes?
A link between genetic variability and clinical phenotypes is
supported in human studies by several observations relating variants
Table 2. Number of gene expression-by-SNP associations at various levels of significance.
Significance
level Minimum R
2 $
Total number
of associations
cis/trans ratio for
associations
Total number of
associated
expressions
(eQTLs)
cis/trans ratio
for eQTLs
Total number of
associated SNPs
(eSNPs)
cis/trans ratio
for eSNPs
,10
26 0.016 93491 2.1 8575 0.5 67190 2.4
,10
28 0.022 54749 7.3 3857 3.0 41425 11.2
,10
210 0.028 42421 9.8 2998 6.0 33339 16.3
,5.78610
212 0.031 37403 10.7 2745 7.1 29912 17.1
,10
215 0.042 27330 12.7 2180 9.5 22591 17.8
,10
220 0.057 19655 14.7 1725 12.8 16883 19.2
,10
225 0.071 15015 16.4 1429 16.2 13045 21.5
,10
235 0.099 9673 17.1 1031 21.6 8516 22.9
,10
250 0.140 5873 14.0 712 28.8 5224 21.7
,10
2100 0.263 1790 10.5 290 28.1 1598 11.1
,10
2150 0.371 922 5.5 156 21.4 772 5.9
,10
2200 0.463 635 3.7 97 15.3 504 3.9
,10
2300 0.606 321 1.7 38 11.7 213 1.7
$Minimum R
2 (proportion of gene expression variability explained by a SNP) observed for a given significance level. Numbers corresponding to study-wise significance are
shown in bold. For investigating cis associations or performing any other hypothesis-based test, lower levels of significance may be considered.
doi:10.1371/journal.pone.0010693.t002
Figure 1. Number of eQTLs according to the significance threshold adopted and corresponding cis/trans eQTL ratio. The vertical arrow
indicates the study-wise level of significance correcting for the number of hypotheses tested. Some eQTLs being associated with both cis and trans-
acting eSNPs, the sum of cis and trans eQTLs is greater than the total number of eQTLs.
doi:10.1371/journal.pone.0010693.g001
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PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10693Figure 2. Comparison of the distributions of P-values of cis eQTLs reported as significant in three previous association studies with
P-values observed in GHS for the same eQTLs. For each of the 3 comparisons, we selected in GHS the subset of gene expressions claimed as
significant in the study of comparison. Only autosomal genes were considered in these comparisons. The data used to generate this figure are
provided in Files S2–S4. See also footnote of Table S3 for details.
doi:10.1371/journal.pone.0010693.g002
Table 3. Number of cis eQTLs identified in previous studies and replicated in GHS.
Stranger et al. Dixon et al. Schadt et al.
Level of
signifi-cance
Number of eQTLs at
level of significance
Percent signifi-
cant in GHS*
Number of eQTLs at
level of significance
Percent signif-
icant in GHS*
Number of eQTLs at
level of significance
Percent signifi-
cant in GHS*
.10
28 86 55.8 110 50.9 928 47.9
10
28–10
210 63 69.8 162 50.0 168 57.7
10
210–10
215 144 63.2 237 54.8 211 57.3
10
215–10
220 60 70.0 102 60.7 120 66.7
10
220–10
225 38 89.5 73 65.7 73 67.1
#10
225 48 70.8 89 67.4 103 73.8
All 439 66.7 773 56.5 1603 54.1
* Comparisons were based on sets of gene expressions overlapping between each study and GHS and were restricted to autosomal cis eQTLs. All cis eQTLs considered
significant in each study were retrieved and replication was assessed in GHS (P,3.9610
26 correcting for 12,808 gene expressions).
For Stranger et al [1], data were extracted from Table S2. We considered as significant the associations found in at least 3 HAPMAP populations. For Dixon et al [2], data were
extracted from Table S1 and trans eQTLs were excluded. Matching of probes was done using a table provided by the authors on their web site. For Schadt et al [3], cis eQTLs
considered significant (First.Pass.Indicator set to 1) were extracted from Table S3. For each eQTL, we selected in GHS the P-value of the best cis eSNP. The full data used to
generate this table are provided in Files S2–S4.
doi:10.1371/journal.pone.0010693.t003
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However, this message-passing paradigm has never been evaluated
on a genome-wide basis. We therefore tested whether monocytes
gene expression might mediate the effects of loci recently identified by
GWAS of cardiovascular risk factors. For each locus identified in
GWAS of lipid variables [21], blood pressure (BP) [22] and body
mass index (BMI) [23], we selected the lead SNP or a tag SNP having
an r
2$0.8 with the lead SNP in GHS data. Associations between
lead/tag SNPs and corresponding risk factors were checked in all
GHS subjects for whom genome-wide data was available (n=3,175).
Most previous GWAS loci for circulating lipids were replicated in our
data (Table 4) but only few of the findings of GWAS of BMI and BP
were replicated (Table S2). This low replication is probably due to a
lackof power, asthe maximum R
2 observed in the GWAS of BP [22]
was 0.09% and the power of GHS to replicate such an association
was only 38%.
For each GWAS locus, we examined whether the lead/tag SNP
correlated with any expression trait in GHS data and when a
significant association was found, we checked whether the
expression trait was significantly associated with the risk factor
under consideration. This analysis revealed that very few GWAS
results were compatible with an effect mediated by gene expression
at the locus (Table 4 and Table S2). There were, however, two
exceptions: the first one concerned the LPL locus, where the minor
allele of rs17489282 was associated with higher HDL-cholesterol
(P=5.91610
25) and LPL expression (P=2.18610
26), while HDL-
cholesterol and LPL expression were positively correlated
(P=6 610
24), consistent with an effect mediated by LPL; the
second one concerned the association between the 1p13.3 locus
and LDL-cholesterol. This locus encompasses three potential
candidate genes, CELSR2, PSRC1 and SORT1, and it has been
suggested that CELSR2 or SORT1 could be responsible for the
reported associations of this locus with LDL [3,24,25]. In our data,
the minor allele of rs629301 (a perfect tag of the lead SNP
identified by GWAS), was associated with lower LDL-cholesterol
(P=2.6610
24) and higher PRSC1 expression (P=2.3610
256)
Figure 3. Comparison of the heritability of cis eQTLs estimated in the SAFHS study with the R
2 of the corresponding cis eQTLs in
GHS. Data were extracted from Supplementary Table 4 in Go ¨ring et al. [4] and comparisons were restricted to genes having a corresponding gene
symbol in GHS. Heritability in the SAFHS was estimated by linkage analysis and accounts for the whole variability at a locus while R
2 refers to a single
eSNP (the best eSNP) and therefore underestimates the global variability affecting gene expression at a locus. The data used to generate this figure
are provided in File S5. The median R
2 was globally lower than the heritability, consistent with the fact that the R
2 is referring to a single SNP whereas
heritability reflects the whole genetic variation at a locus.
doi:10.1371/journal.pone.0010693.g003
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correlated (P=0.019). Results for CELSR2 were much less
consistent and SORT1, the third gene at the locus, was not cis-
modulated in monocytes.
Several loci associated with coronary artery disease (CAD) have
been identified by GWAS [26–29]. The strongest association
involves SNPs in the 9p21 region. Recently it was reported that
deletion in mice of the region orthologous to the 9p21 CAD
interval in human affects the expression of the nearby cdkn2a and
cdkn2b genes as well as the properties of proliferation of vascular
cells [30]. The Cyclin-dependent kinase inhibitor coding genes,
CDNK2A and CDNK2B, are also located close to the CAD locus in
humans. CDKN2A expression in monocytes was not detected in
our study, we therefore focused our analysis on CDKN2B. All SNPs
available in GHS in the region encompassing the CAD locus were
tested for association with the expression of CDKN2B. Figure 4
shows that CDKN2B expression was strongly associated with
several SNPs located in a region upstream of the gene sequence
(P,10
260). However, these SNPs were not associated with CAD
(this result was obtained in a yet unpublished GWAS comparing
GHS individuals to a cohort of CAD patients), whereas proxies of
the CAD-associated SNPs were unrelated with CDKN2B expres-
sion (see legend of Figure 4 for more details). The SNPs associated
with CDKN2B expression are located within the sequence of the
non-coding alternatively spliced gene ANRIL (also named
CDKN2BAS) whose implication in the association with CAD has
been hypothesized [31]. Although our results are limited by the
fact that neither CDKN2A nor ANRIL expressions could be
Table 4. Loci identified in GWAS of circulating lipids – associations of lead/tag SNPs with phenotypes and expression, and of
expression with phenotype in GHS.
Lead SNP
in GWAS Phenotype Chr
Position
(Mb) Genes in region
Tag SNP in
Affy 6.0 with
r
2.0.8
r
2 between
lead SNP
and tag SNP
Association
between tag
SNP and
phenotype
(P-value)
eQTL
associated
with tag
SNP
Association
between tag
SNP and eQTL
(P-value)
Association
between
eQTL and
phenotype
(P-value)
rs10889353 TG 1 62.83 DOCK7 rs10889353 1.00 1.86E-04 DOCK7 7.09E-52 0.3970
rs646776* LDL 1 109.53 CELSR2/PSRC1/
SORT1
rs629301 1.00 2.62E-04 PSRC1 2.34E-56 0.0190
CELSR2 7.56E-06 0.6195
rs693 LDL 2 21.14 APOB rs693 1.00 1.61E-04 none
rs6754295 HDL 2 21.12 APOB rs673548 0.86 0.0435 none
rs673548 TG 2 21.15 APOB rs673548 1.00 4.10E-05 none
rs780094 TG 2 27.65 GCKR rs780094 1.00 3.15E-08 none
rs6756629 LDL 2 43.98 ABCG5 rs4953023 1.00 7.87E-05 none
rs3846662 LDL 5 74.69 HMGCR rs12654264 0.84 9.26E-06 none
rs12670798 LDL 7 21.38 DNAH11 none
rs2240466 TG 7 72.3 MLXIPL rs2074755 1.00 0.0015 none
rs2083637 HDL 8 19.91 LPL rs17489282 1.00 5.91E-05 LPL 2.18E-06 0.0006
rs2083637 TG 8 19.91 LPL rs17489282 1.00 3.31E-07 LPL 2.18E-06 0.3520
rs3905000 HDL 9 104.74 ABCA1 rs3890182 1.00 0.33 none
rs7395662 HDL 11 48.48 MADD-FOLH1 rs7395662 1.00 0.17 MYBPC3 1.17E-09 0.1435
SPI1 4.42E-06 0.0222
rs174570 LDL 11 61.35 FADS2/3 rs174570 1.00 0.0386 none
rs12272004 TG 11 116.11 APO(A1/A4/A5/C3) rs10488699 1.00 1.63E-06 none
rs1532085 HDL 15 56.47 LIPC none
rs1532624 HDL 16 55.56 CETP none
rs2271293 HDL 16 66.46 CTCF-PRMT8 rs2271293 1.00 0.0145 DPEP3 5.09E-17 0.8275
DUS2L 5.15E-42 0.1410
GFOD2 1.48E-17 0.6400
LCAT 6.00E-06 0.3347
PARD6A 7.88E-07 0.8772
PRMT7 2.03E-06 0.1690
rs4939883 HDL 18 45.42 LIPG rs7240405 1.00 0.0233 none
rs2228671 LDL 19 11.07 LDLR none
rs157580 LDL 19 50.09 TOMM40-APOE none
GWAS loci were taken from Table 2 in ref. 21.
*This SNP was also found in GWAS of CAD. The association between tag SNP and phenotype was tested in the 3,175 GHS subjects having GWV data. Association between
eQTL and tag SNP or phenotype was tested in the 1,490 GHS subjects having GWE data. In bold are shown the loci for which the SNP-phenotype association found in GWAS is
compatible with mediation by gene expression. Similar analyses for BMI and BP are given in Table S2.
doi:10.1371/journal.pone.0010693.t004
The Monocytes Transcriptome
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expression are different from those that are known to affect CAD
risk (Figure 4).
Expression traits associated with risk factors
To investigate gene expression in relation to risk factors (age,
gender, BMI, HDL and LDL cholesterol, triglycerides, Systolic
and Diastolic Blood pressure, smoking and plasma CRP), the
study-wise significance threshold was set at 3.9610
27 to correct
for the number of risk factors (n=10) and expressions (n=12,808)
tested. Overall, 1,662 expression traits (13.0%) were associated
with at least one risk factor (Table 5 and File S6). Gender and age
were the two major factors influencing expression levels (807 gene
expressions were affected by gender and 396 by age). BMI,
smoking and C-reactive protein (CRP) levels were also correlated
with numerous expression traits (230, 294 and 328, respectively).
Conversely, few associations with BP and lipids were observed
(Table 5).
Genetic and non-genetic factors act additively on gene
expression
Cis eQTLs were over-represented among expression traits that
were also affected by gender, age, BMI, smoking and CRP, with
odds ratios as high as 3.24 for cigarette smoking (Table 5). This
suggests that some genes are more responsive than others to the
influence of multiple factors. For expression traits that were
simultaneously associated with cis eSNPs and risk factors (n=465),
we determined the joint effects of the two sources of variability on
expression level. For this purpose, each eQTL was modelled as a
function of the best cis-acting eSNP, the associated risk factor and
Figure 4. The loci affecting CDKN2B expression and CAD on chromosome 9p21 are independent. The lead SNP rs1333049 generally
reported at the CAD locus was not present on the Affymetrix 6.0 array, we therefore selected its best proxy, rs10757272 (position 22078260, r
2=0.9
with rs1333049), using SNAP (https://www.broadinstitute.org/mpg/snap). Positions of genotyped SNPs are shown using a green link and position of
the proxy SNP, rs10757272, is represented by a green triangle. The red curve reflect the –log10(P-value) for the association between SNPs and
CDKN2B expression. The LD (r
2) between pairs of SNPs is shown at the bottom of the figure using a range of colors between white (r
2=0) and black
(r
2=1). The CDKN2B and CAD-associated SNPs are located in different blocks of LD strongly suggesting that the genetic effects on CDKN2B expression
and CAD are independent.
doi:10.1371/journal.pone.0010693.g004
The Monocytes Transcriptome
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associated with the same eQTL, each of them was tested
separately for interaction with the corresponding SNP. The best
FDR-corrected P-values for interaction (File S7) were 0.014 (ISCU
expression, gender and rs4830487) and the second one was 0.042
(HIST1H2AE expression, smoking and rs16891378). This first
genome-wide exploration of interaction between cis eSNPs and
risk factors on gene expression therefore suggests that the two
sources of variability mostly act additively on expression. This is
illustrated for eQTLs affected by smoking in Figure 5. It must be
noted however that despite the large size of this study, its power
may nevertheless be insufficient to assess weak interaction.
Expressions influenced by genetic and risk factors are
enriched in immunity and defense genes
An ontology analysis using the Panther system demonstrated
that, by reference to the list of 12,808 genes expressed in
monocytes, the set of 465 expression traits affected by multiple
sources of variability was enriched in ‘‘Immunity and defense’’
genes (69 observed/35.8 expected, P=4.5610
26), especially in the
sub-categories of ‘‘Macrophage-mediated immunity’’ (18/3.6,
P=7.5610
26).
The variability of each risk factor can be characterized by
a limited set of independent gene expressions
The preceding analyses revealed that each risk factor was
associated with a large number of expression traits, thus
emphasizing the multiple inter-relations existing between the
transcriptomic and risk factor profiles of an individual. While it is
important from a biological and mechanistic perspective to
characterize at best all the genes that are influenced by a given
condition, from a clinical perspective, it might be more relevant to
identify a limited set of gene expressions that could efficiently
discriminate individuals with different risk profiles. Indeed,
because of the tight co-regulation of genes within biological
systems, numerous gene expressions are inter-correlated and
consequently, their association with risk factors are not indepen-
dent. To account for this inter-dependency, we conducted a
multivariate analysis to identify expression traits that were
independently associated with each risk factor.
To obtain reliable results, we randomly divided the study
population into two sub-samples of equal size which were used for
screening and validation purposes respectively (see Materials and
Methods). In these analyses, each risk factor was considered
separately whereas all expression traits were envisaged jointly for
their potential association with the risk factor, considered here as
the dependent variable. The screening/validation procedure was
repeated 250 times and for each risk factor, we report expression
traits associated (P,0.01) with the risk factor in more than 25% of
the replicates. This stringent approach led to the identification of
106 independent expression correlates for the ten risk factors
(Table 6), a much reduced number compared to the 1,662
expression traits previously identified by the one-to-one association
analysis presented in Table 5.
Gender and age. Even after exclusion of sex-linked genes,
gender was independently associated with the largest number of
expression traits (n=31) which, considered all together,
contributed to a highly significant discrimination between males
and females (P,10
2100). By contrast the number of expression
traits independently associated with age was more limited (n=12).
BMI and CRP. Both factors were independently associated
with 12 and 14 expression traits respectively. Inspection of the
genes listed in Table 6 shows that several of them, including
CX3CR1, CD209, CLEC10A, FCER1A, FCGBP, C1RL, C1QB,
CD36, ADM and VSIG4, encode proteins involved in the
differentiation or maturation of immunity-related cells and in
host defence [32–38]. We may speculate that the variability of
expression of these genes is the consequence of an already present
heterogeneity of monocytes [39,40] or reflects a particular
transcription pattern that prefigures future functional changes.
The example of CX3CR1 which was positively associated with both
BMI and CRP is particularly interesting as this gene encodes the
fractalkine receptor whose role is essential in the migration of
Table 5. Number of expression traits associated with risk factors and cis eSNPs.
Risk factor
Number of expression
traits associated with the
specified risk factor
Number (%) of expression
traits also associated with
cis eSNPs Odds ratio (95% CI)*
Gender 807 230 (28.5%) 1.73 (1.47–2.03)
Age 396 94 (23.7%) 1.31 (1.03–1.66)
BMI 230 72 (31.3%) 1.92 (1.45–2.56)
HDL 9 1 (11.1%) ND
LDL 1 0 ND
Triglycerides 9 3 (33.3%) ND
SBP 48 6 (12.5%) 0.59 (0.25–1.40)
DBP 18 2 (11.1%) ND
Smoking 294 126 (42.9%) 3.24 (2.56–4.10)
CRP 328 116 (35.4%) 2.34 (1.86–2.95)
All (irrespective of any
association with risk factor)
12,808 2,477 (19.3%)
Study-wise levels of significance were considered for associations of expression traits with risk factors and SNPs (3.9610
27 and 5.78610
212, respectively). Associations of
expression traits with BMI, CRP and smoking were adjusted for age and sex, and association with HDL, LDL, triglycerides, SBP and DBP were additionally adjusted for
BMI.
*Odds ratio (OR) of being influenced by a cis eSNP for an expression trait associated with a given risk factor. For example, gender-related expression traits have an OR of
1.73 of being influenced by cis eSNPs by comparison to expression traits unrelated to gender. ND: not determined because of small numbers.
doi:10.1371/journal.pone.0010693.t005
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atherosclerotic lesions [41].
Lipids. ABCA1 and ABCG1 gene expressions were both
associated with circulating lipids. The proteins encoded by these
genes are key players in reverse cholesterol transport and the
regulation of lipid-trafficking mechanisms in macrophages
respectively [42,43]. MYLIP (Idol) is a ligase involved in the
ubiquitination and degradation of LDL receptors [44,45] and
SCD is a stearoyl-CoA desaturase involved in the conversion of
saturated into monounsaturated fatty acids that regulates lipid
metabolism and may be modulated by dietary intake [46].
Blood pressure. One of the main independent correlates of
SBP was ARID5B (MRF2), whose relevance in the physiology of BP
regulation is supported by its role as a regulator of smooth muscle
differentiation and proliferation [47]. GFOD1, another expression
correlate of SBP and DBP is a gene of unknown function which
has been associated with attention deficit hyperactivity disorder
[48].
Cigarette smoking has a major impact on gene
expression and atherosclerosis
Smoking was independently associated with 18 expression traits
(Table 6) which, considered all together, contributed to a highly
significant discrimination between smokers and non smokers
(P,10
2107,R
2.50%). Nine of these genes were modulated by cis
eSNPs (Table 7) and as already mentioned above, the genetic and
smoking effects on these gene expressions were additive (Figure 5).
Among the 18 expression traits associated with smoking,
SASH1, P2RY6 and PTGDS were systematically retrieved in all
Figure 5. Effect of the best cis eSNP and smoking on expression of smoking-related eQTLs. The proportion of variability of expression
explained by the best cis eSNP varied from 3.1% for CLEC10A to 27.2% for GFRA2 while the proportion explained by smoking varied from 2.8% for
SMAD6 to 21.6% for SASH1. The lowest P-value for interaction between SNP and smoking was 0.02 for STAB1.
doi:10.1371/journal.pone.0010693.g005
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suppressor gene [49], P2RY6 encodes a G-protein-coupled
receptor involved in the proinflammatory response to UDP in
monocytes [50] and PTGDS encodes a prostaglandin D synthase
involved in smooth muscle contraction/relaxation and inhibition
of platelet aggregation, two functions known to be modified by
tobacco consumption. Recently, in a GWE study of leukocytes
RNA, PTGDS and SASH1 expressions were found associated with
cotinine, a metabolite of nicotine used as a marker of tobacco
exposure [51].
Cigarette smoking is a major risk factor for atherosclerosis [52].
In GHS participants, the prevalence of atherosclerotic plaques in
the right and left carotid arteries, assessed by echography, was
strongly increased in smokers (P=9.1610
27 after adjustment for
age and gender). Among the 18 gene expressions independently
associated with smoking, four were individually correlated with the
number of carotid plaques, PTGDS (P=1.8610
27) negatively and
MMP25 (P=3.5610
24), SASH1 (P=1.4610
25) and WWC3
(P=6.3610
24) positively (Table 7). In a multivariate model
including the four expression traits and smoking, as well as age and
gender, PTGDS (P=5.7610
24) and SASH1 (P=0.012) remained
significantly associated with the number of plaques whereas
MMP25 (P=0.09), WWC3 (P=0.10) and smoking (P=0.5) were
no longer significant, suggesting that the association between
smoking and atherosclerosis was mostly reflected (or mediated) by
its effect on the expression of these four genes. The fact that
PTGDS and SASH1 expression remained associated with carotid
plaques after adjustment on smoking status may indicate a broader
implication of these genes in atherosclerosis than the sole effect
induced by smoking. However it is also possible that the expression
of these two genes more faithfully reflects tobacco consumption
than the dichotomous variable used to define smoking. This
illustrates the dual aspect of the transcriptome which may be
viewed either as an element in a causal chain or as reflecting
ongoing processes with no implied causation. Because genetics
may help to dissect causal pathways, we examined whether the
best cis eSNPs associated with expression of the smoking-related
genes were also associated with carotid atherosclerosis, but no such
association was detected (Table 7).
Discussion
This large-scale investigation of the transcriptome of monocytes
in healthy individuals provides new biological insights into the
mechanisms by which gene expression might contribute to disease
pathogenesis. In the line of previous studies [1–5], we could build a
detailed map of cis-regulated eQTLs in monocytes. Even if cell-
specific eQTLs exist [53], a large fraction of them are likely to be
common to other cell types, and the eQTL map provided here
constitutes the most extensive one so far.
Despite the large number of eQTLs identified, the transcrip-
tome of circulating monocytes, contrary to initial expectations
[7–10], appeared of modest help to dissect the relationship
between genome variability and complex human traits such as
cardiovascular risk factors. One explanation for this finding might
be that monocytes are not the most relevant cells for unravelling
links between genome variation and the risk factors investigated.
With regard to circulating lipids for example, only 28 of the 45
genes located in regions harbouring SNPs associated with
circulating lipids in GWAS [24] were expressed in monocytes.
The difficulty to corroborate the messenger paradigm in human
clinical studies may also relate to the fact that the linear model of
Table 6. Subsets of expression traits showing robust independent association with the different risk factors in the validation
sample.
Risk factor
Median (range) of the global
P-values across replicates*
List of gene expressions associated with risk
factor after adjustment on covariates
$
Gender
# All P,10
2100 CCDC106, MMEL1, ANKRD57, CXCR7, FCGR2B, SOX15, FCGBP, LPXN, CD24, HOXA9, PTK6,
DDX43, RAB11FIP1, PTK2, CLEC4G, ADARB1, PROK2, MYBPH, PER3, TPPP3, MPO, FAM24B,
EMR3, ENOSF1, TPM2, PTTG1IP, CELSR3, CD1A, FOLR2, BOLA3, OPLAH
Age 1.1610
250
(2.9610
270–3.6610
237)
PARP3, PDGFRB, NEFH, P2RY2, SPINK2, GPER, NFKBIZ, ZSCAN18, IGLL1, BLK, ITM2C, C1RL
BMI 1.5610
237
(2.6610
250–2.7610
226)
CX3CR1, MAP3K6, FCGBP, CD209, LYPD2, VSIG4, RPGRIP1, PACAP, LGALS3BP, ELA2, CD36,
ABCA1
HDL-chol 5.5610
210
(2.2610
215–2.7610
23)
PRDM1, SCD, DPEP2,TMEM43
LDL-chol 2.3610
23
(3.8610
27–0.5)
BYSL, ABCA1
Triglycerides 4.2610
26
(2.1610
211–0.08)
MYLIP, PHGDH, ABCA1, ELA2, ABCG1, SASH1
SBP 5.0610
220
(4.6610
227–2.6610
212)
CRIP1, GFOD1, DHRS9, NR4A2, TSC22D3, ARID5B, PAPSS2, HVCN1
DBP 1.8610
210
(3.6610
216–1.2610
24)
GFOD1, CRIP1, TPPP3, NR4A2,EMP1
CRP 6.1610
251
(7.3610
267–2.0610
230)
FAM20A, CETP, FCGBP, COL9A2, C1RL, ADM, CREB5, APBB1IP, CX3CR1, C1QB, MS4A4A,
FCER1A, ALDH1A1, FLVCR2
Smoking 9.7610
2108
(1.9610
2128–3.7610
284)
SASH1, P2RY6, PTGDS, PID1, CYP4F22, MMP25, WWC3, FUCA1, PDE4B, STAB1, GFRA2,
CLEC10A, CAMK1D, DHRS9, CNTNAP2, IQCK, ITGB7, SMAD6,
*The global P-value is the P-value obtained by comparing the model with all significant expression traits and covariates to the model with covariates only.
Expressions that are underlined are associated negatively to the risk factor (or to male gender), others are associated positively (or to female gender).
$Covariates: age and gender for BMI, CRP and smoking; age, gender and BMI for lipids and BP.
#Gender-associated traits were selected from autosomal genes only.
doi:10.1371/journal.pone.0010693.t006
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variability, expression and phenotype may be too simplistic to
account for a much more complex biological reality. The effects of
genetic variants may be too weak to allow detection even in a
study of this size. It is also important to keep in mind that most
reported eSNPs are acting in cis, whereas trans eSNPs may actually
be those that mainly drive the changes in gene expression that
affect disease risk.
Most importantly, the present study highlighted for the first time
the strong link existing between the transcriptome of an individual
and his (her) clinical and epidemiological profile. The fact that the
transcriptome tightly mirrors the variability of risk factors at a
cellular level may have profound implications from a biological
and clinical perspective. Until now, the traditional way of viewing
the role of genes in the susceptibility to human diseases was
through the effect of their variability of sequence. The present
findings suggest that another important, if not greater, impact of
genes on human phenotypes relates to the variability of their
expression, whatever the origin of this variability. The global
association observed between most cardiovascular risk factors and
the transcriptome and the fact that each risk factor could be
characterized by a limited and specific set of independent gene
expressions further suggests that this relationship might be
clinically relevant. This was particularly well illustrated by the
response of the transcriptome to cigarette smoking. We showed
that less than 20 genes among the 12,000 expressed in monocytes
could highly discriminate smokers and non-smokers, and among
them, four genes were sufficient to account for the strong
association existing between smoking and atherosclerosis. Whether
these genes are causally involved in the mechanisms linking
smoking to the development of atherosclerotic plaques or whether
they are only markers of ongoing pathological processes remains to
be elucidated.
In conclusion, the variability of the transcriptome of monocytes
can be viewed from two perspectives. On one hand it reflects the
accumulation of effects originating from the genome and the
environment and may inform on a number of ongoing processes
relevant to disease. On the other hand, it may reflect or anticipate
differences in monocytes biology that could have pathophysiolog-
ical implications. This dual perspective suggests that a better
understanding of the sources of variability of the transcriptome of
monocytes and other easily accessible cells, will contribute in an
important way to our understanding of complex diseases.
Materials and Methods
Ethic statement
The study protocol and drawing of the blood sample have been
approved by the local ethics committee and by the local and
federal data safety commissioners (Ethik-Kommission der Land-
esa ¨rztekammer Rheinland-Pfalz). All subjects included signed an
informed consent.
Study population
The Gutenberg Heart Study (GHS) is designed as a community-
based, prospective, observational single-center cohort study in the
Rhein-Main region in western mid-Germany. The primary aim of
the study is to improve the individual cardiovascular risk
Table 7. Smoking-related expression traits: association of expression with cis-acting eSNP, smoking and extent of atherosclerosis.
Smoking-related gene
expressions
Association of the best cis
eSNP with expression
Association of the
best cis eSNP with
the extent of
atherosclerosis
Association of expression
with smoking
Association of expression with
the extent of atherosclerosis
SNP number P-value t- value P-value t- value P-value t- value P-value
CAMK1D rs4478891 1.1610
226 0.7 0.51 27.4 2.3610
213 23.1 0.002
CLEC10A rs367953 3.6610
212 0.5 0.65 13.0 5.4610
237 20.4 0.68
CNTNAP2 rs1110144 8.6610
212 21.1 0.28 6.5 7.3610
211 1.7 0.082
CYP4F22 rs11253478 1.5610
26 0.0 1.00 217.5 1.8610
262 22.2 0.027
DHRS9 rs1386426 4.3610
27 2.5 0.012 26.3 3.5610
210 0.2 0.82
FUCA1 rs9424398 6.8610
242 1.0 0.34 13.7 1.4610
240 2.1 0.035
GFRA2 rs1479056 1.6610
2108 0.5 0.62 13.3 3.1610
238 0.8 0.44
IQCK rs1879894 1.1610
27 0.6 0.52 27.6 2.7610
214 21.7 0.089
ITGB7 rs17080239 1.0610
26 0.4 0.68 6.3 3.9610
210 0.3 0.73
MMP25 rs7188573 4.7610
218 0.0 1.00 15.6 5.4610
251 3.6 3.51610
24
P2RY6 rs3781305 9.0610
27 21.0 0.34 16.0 1.5610
253 0.5 0.58
PDE4B rs4352802 4.5610
27 21.2 0.24 27.7 1.2610
214 21.8 0.077
PID1 rs4972894 1.1610
225 20.1 0.95 10.5 6.2610
225 1.4 0.16
PTGDS rs10870158 6.0610
29 0.7 0.49 214.0 3.5610
242 25.2 1.77610
27
SASH1 rs17712470 5.6610
214 0.5 0.63 20.5 5.1610
283 4.4 1.38610
25
SMAD6 rs17264185 2.7610
215 21.5 0.13 6.8 9.6610
212 1.6 0.11
STAB1 rs9867823 2.8610
228 0.4 0.68 12.3 2.9610
233 0.7 0.50
WWC3 rs1013478 8.0610
26 21.1 0.26 10.6 1.8610
225 3.4 6.32610
24
Atherosclerosis was assessed by the number of carotid plaques.
Associations of expressions with smoking and number of carotid plaques were adjusted on gender and age. Cis eSNPs significant at a study-wise level (P,5.78610
212)
and associations with carotid plaques significant after correction for multiple testing (n=18 tests) are shown in bold characters.
doi:10.1371/journal.pone.0010693.t007
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contributing to cardiovascular diseases, with a strong emphasis on
atherosclerosis.
A sample of eligible participants was randomly drawn from the
registers of the local registry offices in the city of Mainz and the
district of Mainz-Bingen. This sample was stratified in a ratio of
1:1 for gender and residence, and in equal numbers for decades of
age. Inclusion criteria were an age between 35 and 74 years and a
written consent; exclusion criteria were insufficient knowledge of
the German language to understand explanations and instructions,
and physical or psychic inability to participate in the examinations
in the study center. Individuals were invited for a 5-hour baseline-
examination to the study center where clinical examinations and
collection of blood samples were performed. The present analysis
was based on an initial sample of 3,336 subjects successively
enrolled into the GHS from April 2007 to April 2008. Genomic
DNA was isolated from all participants. Monocyte RNA was
isolated from half of the participants recruited each day to ensure
rapid sample processing and isolation of total RNA. For
approximately 1,500 study participants, both DNA and RNA
were available.
Measurement and definition of cardiovascular risk factors
Blood pressure measurements were performed by an automated
sphygmomanometer blood pressure meter (Omron 705CP-II,
OMRON Medizintechnik Handesgesellschaft GmbH, Germany)
after 5, 8 and 11 minutes of rest. The mean from the 2
nd and 3
rd
standardized measurement was calculated for the systolic and
diastolic blood pressure. For the anthropometric measurements,
calibrated, digital scales (Seca 862, Seca Germany), a measuring
stick (Seca 220, Seca, Germany) and a waist measuring tape were
used. The blood sampling was carried out under fasting
conditions. HDL-cholesterol, LDL-cholesterol, triglycerides and
C-reactive protein (CRP) measurements were performed on an
Architect c8000 by commercially available tests (CRP, Ultra
HDL, Direct LDL and Triglycerides) from Abbott (www.
abbottdiagnostics.de). All tests were measured under standardized
conditions in an accredited laboratory of the institute of clinical
chemistry and laboratory medicine at the University of Mainz.
Smoking was defined by dichotomizing the population into non-
smokers (never smokers and former smokers) and smokers
(occasional smoker, i.e. ,1 cigarette/day, and smoker, i.e. .1
cigarette/day).
Ultrasound of the Carotid Arteries and evaluation of the
number of atherosclerotic plaques
IMT was assessed with an ie33 ultrasound system (Philips, NL)
using an 11 to 3 MHz linear array transducer. Experienced
technologists blinded to participants’ clinical data made all
ultrasound measurements. The IMT was visualized bilaterally at
the far wall of the CCA. In brief, a cursor representing the region
of interest (10 mm) was positioned 1 cm in front of the beginning
before the carotid bulb. Evaluation was performed using an
automatic computerized system (Philips, NL Qlab software) and
triggering was performed according to the Q wave of the ECG to
enable measurement in complete relaxation of the ventricle. IMT
was recorded 1 cm before the carotid bulb in a part without
plaque on the left and right side. As mean IMT, the CCA was
reported with the sum of IMT of the left and right side and
afterwards divided by two. Plaques were defined as thickening of
the IMT of at least 1.5 mm and presence was checked in all
measured arteries. The number of plaques from both sides was
recorded and subjects being classified as plaque positive when at
least one plaque was measured on either side or plaque negative,
when no plaque was recorded.
Genotyping
For each participant genomic DNA was extracted from buffy-
coats prepared from EDTA blood samples (9 mL) using the
method of Miller [54]. Genotyping was performed using the
Affymetrix Genome-Wide Human SNP Array 6.0 (http://www.
affymetrix.com), as described by the Affymetrix user manual.
Genotypes were called using the Affymetrix Birdseed-V2 calling
algorithm and quality control was performed using GenABEL
(http://mga.bionet.nsc.ru/nlru/GenABEL/). Individuals with a
call rate below 97% or a too high autosomal heterozygosity (False
Discovery Rate ,1%) were excluded. After applying standard
quality criteria (minor allele frequency .1%, genotype call rate
.98% and P-value of deviation from Hardy-Weinberg equilib-
rium .10
24), 675,350 out of 900,392 SNPs remained for
analysis.
Separation of monocytes
Separation of monocytes was conducted within 60 min after
blood collection and RNA was extracted the same day. Total
RNA was isolated from monocytes using Trizol extraction and
purification by silica-based columns. To separate monocytes,
8 mL blood was collected using the Vacutainer CPT Cell
Preparation Tube System (BD, Heidelberg, Germany) and
400 mL Rosette Sep Monocyte Enrichment Cocktail (StemCell
Technologies, Vancouver, Canada) was added immediately
after blood collection. Monocytes, not labeled by antibodies,
are collected as a highly enriched fraction at the interface
between plasma and the density medium in the tube. After
separation, cells were washed twice in ice cold PBS buffer
containing 2 mM EDTA. Success of monocyte separation was
controlled using an ADVIA 2120 Analyser (Siemens
Healthcare Diagnostics, Eschborn, Germany) for part of the
samples.
Preparation of RNA
After separation, cells were resuspended in 1.5 mL Trizol
Reagent (Invitrogen, Karlsruhe, Germany) immediately and
frozen at 220uC until isolation of RNA at the same day (maximal
storage time 5 h). After thawing, samples were transferred into
Phase Lock Gel Tubes (Eppendorf, Hamburg, Germany), 200 mL
chloroform was added and phases were separated by centrifuga-
tion at 4600 rpm for 15 min. Purification of total monocytes RNA
was performed using the RNeasy Mini kit (Qiagen, Hilden,
Germany) according to the manufactures’ Animal Cell Spin and
RNA Cleanup protocols including an additional DNase digestion
step. Total RNA was eluted in 20 mL RNase-free water. Yield of
RNA was checked spectrophotometrically by NanoDrop N-1000
measuring the OD260 as well as the ratio OD260 and OD280.
The integrity of the total RNA was assessed through analysis on an
Agilent Bioanalyzer 2100 (Agilent Technologies, Boeblingen,
Germany).
Genome-Wide Expression analysis
GWE analysis was performed on monocytes RNA samples
using the Illumina HT-12 v3 BeadChip (http://www.Illumina.
com). RNA samples were processed in batches of 96 samples. Two
hundred ng of total RNA was reverse transcribed, amplified and
biotinylated using the Illumina TotalPrep-96 RNA Amplification
Kit (Ambion/Applied Biosystems, Darmstadt, Germany). 700 ng
of each biotinylated cRNA was hybridized to a single BeadChip at
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Bead Array Reader.
Pre-processing of expression data
The summary probe-level data delivered by the Illumina scanner
(mean and SD computed over all beads for a particular probe) was
loaded in Beadstudio. The pre-processing done by the Illumina
software, at the level of the scanner and by Beadstudio included:
correction for local background effects, removal of outlier beads,
computation of average bead signal and SD for each probe and
gene, calculation of detection P-values using negative controls
present on the array, quantile normalization across arrays, check
of outlier samples using a clustering algorithm, check of positive
controls. Analyses were carried out on the mean level for all probes
in each gene. To stabilise variance across expression levels, we
applied an arcsinh transformation to the expression data [55].
Compared to a log transformation, this transformation has the
advantage not to discard negative expression values which can
occur in Illumina data.
The Illumina HT-12 BeadChip included 37,804 genes (some
probes being not assigned to RefSeq genes). A gene was declared
significantly expressed in the dataset, i.e. expressed above
background (as measured by the negative controls present on
each array), when the detection P-value calculated by Beadstudio
was ,0.05 in more that 5% of the samples. This resulted in 22,305
genes considered as being significantly expressed in our dataset.
After removing 8,058 putative and/or non well characterized
genes, i.e. gene names starting by KIAA (n=165), FLJ (n=214),
HS (n=4,262), Cxorf (n=842), MGC (n=72), LOC (n=2,503),
12,808 well characterized detected genes remained for
analysis.
Genome wide association analysis
To test all associations between SNPs and expressions in a
reasonable amount of time, a C script calling the GNU Scientific
Library (GSL) ‘‘TAMU ANOVA’’ (www.stat.tamu.edu/,aredd/
tamuanova/) was written. For all significant associations, results
were checked against the R-lm library [56]. When the numbers of
homozygotes for the minor allele of a SNP was lower than 30,
they were grouped with heterozygotes. We used a family-wise
error rate of 0.05 corrected for the number of tested SNP x
expression associations, which corresponds to declare significant
any association with a P-value ,5.78610
212. To increase
robustness, associations significant by ANOVA were further
checked by a Kruskall-Wallis (KW) test and only associations with
a P-value ,10
210 by the KW test were retained. P-values given
in the results and in the GHS-Express database are those
obtained by ANOVA. For SNPs on chromosome X, associations
with gene expression were assessed separately in women and men
and the P-values were combined using the Fisher method [57].
Association of gene expressions with CVD risk factors
The relationship between gene expression and each CHD risk
factor was tested by a linear regression model using R-lm, with
gene expression as the dependent variable. Association with age
was adjusted for gender while association with other risk factors
were adjusted for gender, age and, if specified, BMI. A square root
transformation was applied to CRP levels to remove positive
skewness. A study-wise statistical significance threshold of
3.9610
27 was used to correct for the number of tests (10 risk
factors 612,808 gene expressions). For each expression trait that
was associated with a risk factor and also affected by cis eSNPs, we
tested the interaction between the risk factor and the best cis eSNP
on expression in a regression model.
Global assessment of associations between the
monocyte transcriptome and CVD risk factors
The goal of this analysis was to identify subsets of expression
traits independently associated with each risk factor. To increase
the robustness of the analysis the population was randomly divided
into 2 sub-samples of equal size which were used for screening and
validation purpose respectively. The screening step was focused on
the subsets of expression traits that were associated with each
covariate-adjusted risk factor in univariate analysis at
P,3.9610
26 (Bonferroni correction for 12,808 expressions). Each
risk factor and corresponding subset of expression traits were
included as dependent and predictor variables respectively in a
forward stepwise regression model to identify expression traits that
were independently associated with the risk factor (P,0.01). Gene
expressions selected at the screening step were then jointly tested
in the validation sample for association with the risk factor by
multiple regression analysis. This screening/validation procedure
was repeated 250 times and for each risk factor, expression traits
associated (P,0.01) with the risk factor in more than 25% of the
replicates are reported.
Power of the SNP-expression association analysis
Power was calculated using the program Quanto (http://hydra.
usc.edu/GxE/). Assuming a quantitative expression trait with
mean 0 and SD 1, a sample size of 1,490 subjects, a type I error of
5.78610
212 and an additive allele effect, the study had a 82%
power to detect the effect of a SNP explaining 4% of gene
expression.
Functional classification of genes
An ontology analysis was performed using the Panther database
(http://www.pantherdb.org/). Lists or sublists of genes involved in
associations with eSNPs or risk factors were compared to the
background list of the 12,808 genes. The P-value calculated by the
binomial statistic and Bonferroni-corrected was used.
Quality checking and exclusion of outliers
Population stratification and quality of genotypes and expres-
sion data were tested extensively and outliers were excluded on the
basis of multidimensional scaling analysis (see Methods S2)
GHS_Express
A downloadable SQL database compiling the results of the
various associations tested is available online (http://genecanvas.
ecgene.net/uploads/ForReview/), see also Methods S1. This
database can be used to test specific hypotheses.
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DOC)
Methods S1 GHS-Express database.
The Monocytes Transcriptome
PLoS ONE | www.plosone.org 13 May 2010 | Volume 5 | Issue 5 | e10693Found at: doi:10.1371/journal.pone.0010693.s004 (0.18 MB
DOC)
Methods S2 Data quality checking.
Found at: doi:10.1371/journal.pone.0010693.s005 (0.21 MB
DOC)
File S1 GHS - Characteristics of cis eQTLs.
Found at: doi:10.1371/journal.pone.0010693.s006 (0.40 MB
XLS)
File S2 Comparison cis eQTL in GHS and the study of Stranger
et al.
Found at: doi:10.1371/journal.pone.0010693.s007 (0.10 MB
XLS)
File S3 Comparison cis eQTL in GHS and the study of Dixon
et al.
Found at: doi:10.1371/journal.pone.0010693.s008 (0.14 MB
XLS)
File S4 Comparison cis eQTL in GHS and the study of Schadt
et al.
Found at: doi:10.1371/journal.pone.0010693.s009 (0.28 MB
XLS)
File S5 Comparison cis eQTL in GHS and the study of Goring
et al.
Found at: doi:10.1371/journal.pone.0010693.s010 (0.83 MB
XLS)
File S6 GHS - Expression traits associated with risk factors.
Found at: doi:10.1371/journal.pone.0010693.s011 (0.29 MB
XLS)
File S7 GHS - Interaction cis eSNPs with risk factors.
Found at: doi:10.1371/journal.pone.0010693.s012 (0.12 MB
XLS)
Acknowledgments
We thank John Todd and Chris Wallace for very helpful comments on our
manuscript.
We acknowledge Carolin Neukirch, Fatma Karaman, Jutta Ba ¨hr and
Stefanie Mu ¨ller for technical assistance, Andreas Weith for help during
technical performance of GWV and GWE experiments and Alexandru
Munteanu for assistance in informatics.
Author Contributions
Conceived and designed the experiments: TZ KJL JL NH TM SB FC.
Performed the experiments: TZ PSW CRS RBS DM WR CP CP SB.
Analyzed the data: SS MR AS RC SM MG ME EL VN DT AZ LT FC.
Contributed reagents/materials/analysis tools: TZ PSW KJL HR ME
CRS RBS EL DM WR AZ. Wrote the paper: TZ LT SB FC.
References
1. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, et al. (2007) Population
genomics of human gene expression. Nat Genet 39: 1217–24.
2. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide
association study of global gene expression. Nat Genet 39: 1202–7.
3. Schadt EE, Molony C, Chudin E, Hao K, Yang X, et al. (2008) Mapping the
genetic architecture of gene expression in human liver. PLoS Biol 6: e107.
4. Go ¨ring HHH, Curran JE, Johnson MP, Dyer TD, Charlesworth J, et al. (2007)
Discovery of expression QTLs using large-scale transcriptional profiling in
human lymphocytes. Nat Genet 39: 1208–16.
5. Emilsson V, Thorleifsson G, Zhang B, Leonardson AS, Zink F, et al. (2008)
Genetics of gene expression and its effect on disease. Nature 452: 423–8.
6. Idaghdour Y, Czika W, Shianna KV, Lee SH, Visscher PM, et al. (2010)
Geographical genomics of human leukocyte gene expression variation in
southern Morocco. Nat Genet 42: 62–7.
7. Cookson W, Liang L, Abecasis G, Moffatt M, Lathrop M (2009) Mapping
complex disease traits with global gene expression. Nat Rev Genet 10: 184–94.
8. Nica AC, Dermitzakis ET (2008) Using gene expression to investigate the
genetic basis of complex disorders. Hum Mol Genet 17: R129–134.
9. Cheung VG, Spielman RS (2009) Genetics of human gene expression: mapping
DNA variants that influence gene expression. Nat Rev Genet 10: 595–604.
10. Gilad Y, Rifkin SA, Pritchard JK (2008) Revealing the architecture of gene
regulation: the promise of eQTL studies. Trends Genet 24: 408–415.
11. Crujeiras AB, Parra D, Milagro FI, Goyenechea E, Larrarte E, et al. (2008)
Differential expression of oxidative stress and inflammation related genes in
peripheral blood mononuclear cells in response to a low-calorie diet: a
nutrigenomics study. OMICS 12: 251–261.
12. Bu ¨ttner P, Mosig S, Funke H (2007) Gene expression profiles of T lymphocytes
are sensitive to the influence of heavy smoking: A pilot study. Immunogenetics
59: 37–43.
13. Capel F, Klimca ´kova ´ E, Viguerie N, Roussel B, Vı ´tkova ´ M, et al. (2009)
Macrophages and adipocytes in human obesity: adipose tissue gene expression
and insulin sensitivity during calorie restriction and weight stabilization.
Diabetes 58: 1558–1567.
14. de Magalha ˜es JP, Curado J, Church GM (2009) Meta-analysis of age-related
gene expression profiles identifies common signatures of aging. Bioinformatics
25: 875–881.
15. Tan Q, Zhao J, Li S, Christiansen L, Kruse TA, et al. (2008) Differential and
correlation analyses of microarray gene expression data in the CEPH Utah
families. Genomics 92: 94–100.
16. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, et al. (2006) Tissue-specific
expression and regulation of sexually dimorphic genes in mice. Genome Res 16:
995–1004.
17. Ellegren H, Parsch J (2007) The evolution of sex-biased genes and sex-biased
gene expression. Nat Rev Genet 8: 689–698.
18. Weber C, Zernecke A, Libby P (2008) The multifaceted contributions of
leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev
Immunol 8: 802–15.
19. Sigurdsson S, Nordmark G, Garnier S, Grundberg E, Kwan T, et al. (2008) A
risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed,
correlates with anti-dsDNA and shows additive effects with two risk alleles of
IRF5. Hum Mol Genet 17: 2868–2876.
20. Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC (2010) Regulation of
major histocompatibility complex class II gene expression, genetic variation and
disease. Genes Immun 11: 99–112.
21. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci
influencing lipid levels and coronary heart disease risk in 16 European
population cohorts. Nat Genet 41: 47–55.
22. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al. (2009)
Genome-wide association study identifies eight loci associated with blood
pressure. Nat Genet 41: 666–76.
23. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P,
et al. (2009) Genome-wide association yields new sequence variants at seven loci
that associate with measures of obesity. Nat Genet 41: 18–24.
24. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2009)
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41:
56–65.
25. Linsel-Nitschke P, Heeren J, Aherrahrou Z, Bruse P, Gieger C, et al. (2009)
Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression,
cellular LDL-uptake and serum LDL levels which translates to the risk of
coronary artery disease. Atherosclerosis 208: 183–9.
26. Samani NJ, Braund PS, Erdmann J, Go ¨tz A, Tomaszewski M, et al. (2008) The
novel genetic variant predisposing to coronary artery disease in the region of the
PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol.
J Mol Med 86: 1233–1241.
27. Tre ´goue ¨t D, Ko ¨nig IR, Erdmann J, Munteanu A, Braund PS, et al. (2009)
Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA
gene cluster as a risk locus for coronary artery disease. Nat Genet 41: 283–5.
28. Erdmann J, Grosshennig A, Braund PS, Ko ¨nig IR, Hengstenberg C, et al. (2009)
New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat
Genet 41: 280–282.
29. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, et al. (2009)
Genome-wide association of early-onset myocardial infarction with single
nucleotide polymorphisms and copy number variants. Nat Genet 41: 334–341.
30. Visel A, Zhu Y, May D, Afzal V, Gong E, et al. (2010) Targeted deletion of the
9p21 non-coding coronary artery disease risk interval in mice. Nature 464:
409–12.
31. Jarinova O, Stewart AFR, Roberts R, Wells G, Lau P, et al. (2009) Functional
analysis of the chromosome 9p21.3 coronary artery disease risk locus.
Arterioscler Thromb Vasc Biol 29: 1671–1677.
32. Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, et al. (2009)
CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the
role of CX3CR1 in their response to inflammation. J Exp Med 206: 595–606.
33. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev
Immunol 5: 953–64.
The Monocytes Transcriptome
PLoS ONE | www.plosone.org 14 May 2010 | Volume 5 | Issue 5 | e1069334. Zhou T, Chen Y, Hao L, Zhang Y (2006) DC-SIGN and immunoregulation.
Cell Mol Immunol 3: 279–83.
35. Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL (2007)
CD36 and macrophages in atherosclerosis. Cardiovasc Res 75: 468–77.
36. Zudaire E, Portal-Nu ´n ˜ez S, Cuttitta F (2006) The central role of adrenomedullin
in host defense. J Leukoc Biol 80: 237–44.
37. Chan Y, Chiang M, Tsai Y, Su S, Chen M, et al. (2009) Absence of the
Transcriptional Repressor Blimp-1 in Hematopoietic Lineages Reveals Its Role
in Dendritic Cell Homeostatic Development and Function. J Immunol 183:
7039–7046.
38. He JQ, Wiesmann C, van Lookeren Campagne M (2008) A role of macrophage
complement receptor CRIg in immune clearance and inflammation. Mol
Immunol 45: 4041–4047.
39. Auffray C, Sieweke MH, Geissmann F (2009) Blood Monocytes: Development,
Heterogeneity, and Relationship with Dendritic Cells. Annu Rev Immunol 27:
669–692.
40. Swirski FK, Weissleder R, Pittet MJ (2009) Heterogeneous In Vivo Behavior of
Monocyte Subsets in Atherosclerosis. Arterioscler Thromb Vasc Biol 29:
1424–32.
41. Combadie `re C, Potteaux S, Gao J, Esposito B, Casanova S, et al. (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E
double knockout mice. Circulation 107: 1009–16.
42. Oram JF, Vaughan AM (2006) ATP-Binding cassette cholesterol transporters
and cardiovascular disease. Circ Res 99: 1031–43.
43. Schmitz G, Langmann T, Heimerl S (2001) Role of ABCG1 and other ABCG
family members in lipid metabolism. J Lipid Res 42: 1513–1520.
44. Zelcer N, Hong C, Boyadjian R, Tontonoz P (2009) LXR regulates cholesterol
uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325:
100–104.
45. Lindholm D, Bornhauser BC, Korhonen L (2009) Mylip makes an Idol turn into
regulation of LDL receptor. Cell Mol Life Sci 66: 3399–3402.
46. Flowers MT, Ntambi JM (2008) Role of stearoyl-coenzyme A desaturase in
regulating lipid metabolism. Curr Opin Lipidol 19: 248–256.
47. Watanabe M, Layne MD, Hsieh C, Maemura K, Gray S, et al. (2002)
Regulation of smooth muscle cell differentiation by AT-rich interaction domain
transcription factors Mrf2alpha and Mrf2beta. Circ Res 91: 382–389.
48. Lasky-Su J, Neale BM, Franke B, Anney RJL, Zhou K, et al. (2008) Genome-
wide association scan of quantitative traits for attention deficit hyperactivity
disorder identifies novel associations and confirms candidate gene associations.
Am J Med Genet B Neuropsychiatr Genet 147B: 1345–1354.
49. Rimkus C, Martini M, Friederichs J, Rosenberg R, Doll D, et al. (2006)
Prognostic significance of downregulated expression of the candidate tumour
suppressor gene SASH1 in colon cancer. Br J Cancer 95: 1419–1423.
50. Cox MA, Gomes B, Palmer K, Du K, Wiekowski M, et al. (2005) The
pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory
cytokines and chemokines in monocytic cells stimulated with UDP. Biochem
Biophys Res Commun 330: 467–73.
51. Charles PC, Alder BD, Hilliard EG, Schisler JC, Lineberger RE, et al. (2008)
Tobacco use induces anti-apoptotic, proliferative patterns of gene expression in
circulating leukocytes of Caucasian males. BMC Med Genomics 1: 38.
52. Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and
cardiovascular disease: an update. J Am Coll Cardiol 43: 1731–1737.
53. Dimas AS, Deutsch S, Stranger BE, Montgomery SB, Borel C, et al. (2009)
Common regulatory variation impacts gene expression in a cell type-dependent
manner. Science 325: 1246–1250.
54. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for
extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
55. Huber W, von Heydebreck A, Su ¨ltmann H, Poustka A, Vingron M (2002)
Variance stabilization applied to microarray data calibration and to the
quantification of differential expression. Bioinformatics 18 Suppl 1: S96–104.
56. R Development Core Team (2008) R: A language and environment for
statistical computing. Vienna, Austria: R Foundation for Statistical Computing
Available at: http://www.R-project.org.
57. Fisher R (1932) Statistical Methods for Research Workers. London: Oliver and
Boyd.
The Monocytes Transcriptome
PLoS ONE | www.plosone.org 15 May 2010 | Volume 5 | Issue 5 | e10693